International Journal of Cancer Management

Published by: Kowsar

Viral Respiratory Infections in Patients with Cancer

Yaser Arjeyni 1 , Hossein Goudarzi 2 , Gita Eslami 2 and Ebrahim Faghihloo 2 , *
Authors Information
1 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Cancer Prevention: February 2017, 10 (2); e8084
  • Published Online: February 15, 2017
  • Article Type: Review Article
  • Received: August 31, 2016
  • Revised: October 24, 2016
  • Accepted: February 8, 2017
  • DOI: 10.5812/ijcp.8084

To Cite: Arjeyni Y, Goudarzi H, Eslami G, Faghihloo E. Viral Respiratory Infections in Patients with Cancer, Int J Cancer Manag. 2017 ;10(2):e8084. doi: 10.5812/ijcp.8084.

Abstract
Copyright © 2017, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991; 13 Suppl 6-62[PubMed]
  • 2. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000; 13(3): 371-84[PubMed]
  • 3. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004; 189(2): 233-8[DOI][PubMed]
  • 4. Dawson-Caswell M, Muncie HL Jr. Respiratory syncytial virus infection in children. Am Fam Physician. 2011; 83(2): 141-6[PubMed]
  • 5. Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics. 2004; 114(4)-44[DOI][PubMed]
  • 6. Romano F, Uggeri F, Crippa S, Di Stefano G, Scotti M, Scaini A, et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. J Exp Clin Cancer Res. 2004; 23(2): 195-200[PubMed]
  • 7. Silva FA, Matos JO, de QF, Nucci M. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica. 2005; 90(8): 1110-5[PubMed]
  • 8. Chang M, Wu L, Lu T. Topics in Cancer Survivorship. 2012;
  • 9. Li Y. T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting. J Hematol Oncol. 2012; 5[DOI]
  • 10. Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull. 2008; 87: 49-62[DOI][PubMed]
  • 11. Speer ME, Good AB. The prevention of respiratory syncytial virus infection in children: focus on palivizumab. Clin Med Insights Ther. 2009; 1: 459
  • 12. Ghildyal R, Ho A, Jans DA. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev. 2006; 30(5): 692-705[DOI][PubMed]
  • 13. Rodriguez L, Cuesta I, Asenjo A, Villanueva N. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J Gen Virol. 2004; 85: 709-19[DOI][PubMed]
  • 14. Ulloa L, Serra R, Asenjo A, Villanueva N. Interactions between cellular actin and human respiratory syncytial virus (HRSV). Virus Res. 1998; 53(1): 13-25[PubMed]
  • 15. Hacimustafaoglu M, Celebi S, Bozdemir SE, Ozgur T, Ozcan I, Guray A, et al. RSV frequency in children below 2 years hospitalized for lower respiratory tract infections. Turk J Pediatr. 2013; 55(2): 130-9[PubMed]
  • 16. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999; 282(15): 1440-6[PubMed]
  • 17. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010; 375(9725): 1545-55[DOI][PubMed]
  • 18. Faghihloo E, Salimi V, Rezaei F, Naseri M, Mamishi S, Mahmoodi M, et al. Genetic Diversity in the G Protein Gene of Human Respiratory Syncytial Virus among Iranian Children with Acute Respiratory Symptoms. Iran J Pediatr. 2011; 21(1): 58-64[PubMed]
  • 19. Faghihloo E, Rezaie F, Salimi V, Naseri M, Mamishi S, Mahmoodi M, et al. Molecular epidemiology of human respiratory syncytial virus in Iran. Acta Virol. 2011; 55(1): 81-3[PubMed]
  • 20. Faghihloo E, Yavarian J, Jandaghi NZ, Shadab A, Azad TM. Genotype circulation pattern of human respiratory syncytial virus in Iran. Infect Genet Evol. 2014; 22: 130-3[DOI][PubMed]
  • 21. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007; 92(9): 1216-23[PubMed]
  • 22. Salter A, Laoi BN, Crowley B. Molecular epidemiology of human respiratory syncytial virus subgroups A and B identified in adults with hematological malignancy attending an Irish hospital between 2004 and 2009. J Med Virol. 2011; 83(2): 337-47[DOI][PubMed]
  • 23. Mazzulli T, Peret TC, McGeer A, Cann D, MacDonald KS, Chua R, et al. Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis. 1999; 180(5): 1686-9[DOI][PubMed]
  • 24. Moreira LP, Watanabe AS, Carraro E, da Silva ER, Guatura SB, Granato C, et al. A survey strategy for human respiratory syncytial virus detection among haematopoietic stem cell transplant patients: epidemiological and methodological analysis. Mem Inst Oswaldo Cruz. 2013; 108(1): 119-22[PubMed]
  • 25. Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, et al. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010; 16(9): 1265-71[DOI][PubMed]
  • 26. Small TN, Casson A, Malak SF, Boulad F, Kiehn TE, Stiles J, et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002; 29(4): 321-7[DOI][PubMed]
  • 27. Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, et al. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant. 2001; 28(3): 271-5[DOI][PubMed]
  • 28. Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A, et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood. 2004; 103(5): 1611-7[DOI][PubMed]
  • 29. Roghmann M, Ball K, Erdman D, Lovchik J, Anderson LJ, Edelman R. Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant. 2003; 32(11): 1085-8[DOI][PubMed]
  • 30. Benites EC, Cabrini DP, Silva AC, Silva JC, Catalan DT, Berezin EN, et al. Acute respiratory viral infections in pediatric cancer patients undergoing chemotherapy. J Pediatr (Rio J). 2014; 90(4): 370-6[DOI][PubMed]
  • 31. Chu HY, Chin J, Pollard J, Zerr DM, Englund JA. Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children. Influenza Other Respir Viruses. 2016; 10(3): 205-10[DOI][PubMed]
  • 32. Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust. 2006; 185(10 Suppl)-43[PubMed]
  • 33. Tobita K. [Classification and nomenclature of influenza viruses]. Nihon Rinsho. 1997; 55(10): 2512-4[PubMed]
  • 34. Noda T. Native morphology of influenza virions. Front Microbiol. 2011; 2: 269[DOI][PubMed]
  • 35. Nakajima K. [Influenza virus genome structure and encoded proteins]. Nihon Rinsho. 1997; 55(10): 2542-6[PubMed]
  • 36. Cheung TK, Poon LL. Biology of influenza a virus. Ann N Y Acad Sci. 2007; 1102: 1-25[DOI][PubMed]
  • 37. Hajjar LA, Mauad T, Galas FR, Kumar A, da Silva LF, Dolhnikoff M, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol. 2010; 21(12): 2333-41[DOI][PubMed]
  • 38. Kondo K. Post-infectious fatigue. Japan Med Assoc J. 2006; 49(1): 27
  • 39. Amayiri N, Madanat F. Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection. Pediatr Blood Cancer. 2011; 56(1): 86-9[DOI][PubMed]
  • 40. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008; 167(7): 775-85[DOI][PubMed]
  • 41. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998; 101(3): 643-9[DOI][PubMed]
  • 42. Treanor J. Influenza vaccine--outmaneuvering antigenic shift and drift. N Engl J Med. 2004; 350(3): 218-20[DOI][PubMed]
  • 43. Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. Am J Epidemiol. 1975; 102(6): 553-63[PubMed]
  • 44. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978; 298(11): 587-92[DOI][PubMed]
  • 45. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004; 292(11): 1333-40[DOI][PubMed]
  • 46. Keren R, Zaoutis TE, Bridges CB, Herrera G, Watson BM, Wheeler AB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA. 2005; 294(17): 2188-94[DOI][PubMed]
  • 47. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002; 76(1): 105-15[PubMed]
  • 48. Influenza. 1959; 20
  • 49. Influenza. 1969; 41: 335-748
  • 50. Antoine Flahault MD. Influenza pandemics: past, present and future challenges. Public Health Rev. 2010; 32(1): 319-40
  • 51. Souza TM, Salluh JI, Bozza FA, Mesquita M, Soares M, Motta FC, et al. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS One. 2010; 5(11)[DOI][PubMed]
  • 52. Rodrigues RS, Marchiori E, Bozza FA, Pitrowsky MT, Velasco E, Soares M, et al. Chest computed tomography findings in severe influenza pneumonia occurring in neutropenic cancer patients. Clinics (Sao Paulo). 2012; 67(4): 313-8[PubMed]
  • 53. Tasian SK, Park JR, Martin ET, Englund JA. Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer. 2008; 50(5): 983-7[DOI][PubMed]
  • 54. Pollara CP, Piccinelli G, Rossi G, Cattaneo C, Perandin F, Corbellini S, et al. Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses. BMC Infect Dis. 2013; 13: 127[DOI][PubMed]
  • 55. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010; 60(4): 257-63[DOI][PubMed]
  • 56. Gonzalez Y, Martino R, Rabella N, Labeaga R, Badell I, Sierra J. Community respiratory virus infections in patients with hematologic malignancies. Haematologica. 1999; 84(9): 820-3[PubMed]
  • 57. Porter DD, Porter HG. Respiratory viral antigens in autopsy lung tissue specimens from patients with cancer or myocardial infarction. Clin Infect Dis. 1999; 29(2): 437-40[DOI][PubMed]
  • 58. Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, et al. Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study. Medicine (Baltimore). 2015; 94(50)[DOI][PubMed]
  • 59. Soderman M, Rhedin S, Tolfvenstam T, Rotzen-Ostlund M, Albert J, Broliden K, et al. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study. PLoS One. 2016; 11(6)[DOI][PubMed]
  • 60. Gandhoke I, Aggarwal R, Lal S, Khare S. Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian J Pediatr. 2006; 73(12): 1095-7[PubMed]
  • 61. Munro SC, Trincado D, Hall B, Rawlinson WD. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health. 2005; 41(8): 449-52[DOI][PubMed]
  • 62. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis. 1995; 20(3): 665-70[PubMed]
  • 63. Pannuti CS, Vilas Boas LS, Angelo MJ, Amato Neto V, Levi GC, de Mendonca JS, et al. Cytomegalovirus mononucleosis in children and adults: differences in clinical presentation. Scand J Infect Dis. 1985; 17(2): 153-6[PubMed]
  • 64. Landolfo S, Gariglio M, Gribaudo G, Lembo D. The human cytomegalovirus. Pharmacol Ther. 2003; 98(3): 269-97[DOI]
  • 65. Britt B, Human Herpesviruses: Biology, Therapy and Immunoprophylaxis. 2007; : 311-23
  • 66. Kagele D, Gao Y, Smallenburg K, Pari GS. Interaction of HCMV UL84 with C/EBPalpha transcription factor binding sites within oriLyt is essential for lytic DNA replication. Virology. 2009; 392(1): 16-23[DOI][PubMed]
  • 67. Kim YE, Ahn JH. Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase processivity factor in promoting DNA replication of human cytomegalovirus. J Virol. 2010; 84(17): 8409-21[DOI][PubMed]
  • 68. Li R, Zhu J, Xie Z, Liao G, Liu J, Chen MR, et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe. 2011; 10(4): 390-400[DOI][PubMed]
  • 69. Prichard MN. Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev Med Virol. 2009; 19(4): 215-29[DOI][PubMed]
  • 70. Reeves M, Woodhall D, Compton T, Sinclair J. Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol. 2010; 84(14): 7185-94[DOI][PubMed]
  • 71. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, et al. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest. 2010; 120(9): 3191-208[DOI][PubMed]
  • 72. Tandon R, Mocarski ES. Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J Virol. 2008; 82(19): 9433-44[DOI][PubMed]
  • 73. Yu X, Shah S, Lee M, Dai W, Lo P, Britt W, et al. Biochemical and structural characterization of the capsid-bound tegument proteins of human cytomegalovirus. J Struct Biol. 2011; 174(3): 451-60[DOI][PubMed]
  • 74. Jojima H. Early diagnosis and treatment of pulmonary opportunistic infection by using polymerase chain reaction and beta-glucan in patients with hematological neoplasms. Kurume Med J. 2001; 48(2): 117-27[PubMed]
  • 75. Chang H, Tang TC, Hung YS, Lin TL, Kuo MC, Wang PN. Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series. Chang Gung Med J. 2011; 34(1): 65-74[PubMed]
  • 76. Haas LE, Thijsen SF, van Elden L, Heemstra KA. Human metapneumovirus in adults. Viruses. 2013; 5(1): 87-110[DOI][PubMed]
  • 77. Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: review of an important respiratory pathogen. Int J Infect Dis. 2014; 25: 45-52[DOI][PubMed]
  • 78. Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev. 2006; 19(3): 546-57[DOI][PubMed]
  • 79. Walsh EE, Peterson DR, Falsey AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008; 168(22): 2489-96[DOI][PubMed]
  • 80. Falsey AR. Respiratory syncytial virus infection in elderly and high-risk adults. Exp Lung Res. 2005; 31 Suppl 1: 77[PubMed]
  • 81. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012; 206(1): 56-62[DOI][PubMed]
  • 82. Williams JV, Martino R, Rabella N, Otegui M, Parody R, Heck JM, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis. 2005; 192(6): 1061-5[DOI][PubMed]
  • 83. Kamboj M, Gerbin M, Huang CK, Brennan C, Stiles J, Balashov S, et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect. 2008; 57(6): 464-71[DOI][PubMed]
  • 84. Washburne JF, Bocchini JJ, Jamison RM. Summertime respiratory syncytial virus infection: epidemiology and clinical manifestations. South Med J. 1992; 85(6): 579-83[PubMed]
  • 85. Denny FW, Clyde WJ. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr. 1986; 108(5 Pt 1): 635-46[PubMed]
  • 86. Glezen WP, Frank AL, Taber LH, Kasel JA. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis. 1984; 150(6): 851-7[PubMed]
  • 87. Murphy B, Phelan PD, Jack I, Uren E. Seasonal pattern in childhood viral lower respiratory tract infections in Melbourne. Med J Aust. 1980; 1(1): 22-4[PubMed]
  • 88. Carballal G, Videla CM, Espinosa MA, Savy V, Uez O, Sequeira MD, et al. Multicentered study of viral acute lower respiratory infections in children from four cities of Argentina, 1993-1994. J Med Virol. 2001; 64(2): 167-74[PubMed]
  • 89. Downham MA, McQuillin J, Gardner PS. Diagnosis and clinical significance of parainfluenza virus infections in children. Arch Dis Child. 1974; 49(1): 8-15[PubMed]
  • 90. Lewis VA, Champlin R, Englund J, Couch R, Goodrich JM, Rolston K, et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis. 1996; 23(5): 1033-7[PubMed]
  • 91. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003; 16(2): 242-64[PubMed]
  • 92. Liu WK, Liu Q, Chen DH, Liang HX, Chen XK, Huang WB, et al. Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis. 2013; 13: 28[DOI][PubMed]
  • 93. Vainionpaa R, Hyypia T. Biology of parainfluenza viruses. Clin Microbiol Rev. 1994; 7(2): 265-75[PubMed]
  • 94. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis. 1997; 175(4): 807-13[PubMed]
  • 95. Maeng SH, Yoo HS, Choi SH, Yoo KH, Kim YJ, Sung KW, et al. Impact of parainfluenza virus infection in pediatric cancer patients. Pediatr Blood Cancer. 2012; 59(4): 708-10[DOI][PubMed]
  • 96. Srinivasan A, Wang C, Yang J, Inaba H, Shenep JL, Leung WH, et al. Parainfluenza virus infections in children with hematologic malignancies. Pediatr Infect Dis J. 2011; 30(10): 855-9[DOI][PubMed]
  • 97. Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, et al. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012; 119(12): 2738-45[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments